Figure 2.
Changes in PCs after switching to avatrombopag. (A) Median PCs from baseline (BL) to day 90 after switching to avatrombopag (total population) and (B) percentage of pts with a PC ≥50 × 109/L to ≤200 × 109/L at BL and on days 15, 30, 60, and 90. pts, patients.

Changes in PCs after switching to avatrombopag. (A) Median PCs from baseline (BL) to day 90 after switching to avatrombopag (total population) and (B) percentage of pts with a PC ≥50 × 109/L to ≤200 × 109/L at BL and on days 15, 30, 60, and 90. pts, patients.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal